🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

On 31 Jan, European IHI Prominent consortium including Alzheimer Europe, held an online consultation with people with dementia and carers to develop ethically sound and accessible patient reports for people diagnosed with dementia alzheimer-europe.org/news/prominent…

A new study in Dementia and Geriatric Cognitive Disorders explores clinicians' perspectives on clinical decision support systems for dementia & #Alzheimer’s disease. Conducted as part of the Innovative Health Initiative-funded IHI Prominent project. Read more: alzheimer-europe.org/news/clinician…

We are pleased to share that the European Commission approved the amendment to the Innovative Health Initiative IHI Prominent grant agreement. We would like to officially welcome our new partners, Danish Dementia Research Centre, Oslo University Hospital & DZNE to the team! vimeo.com/835447757?shar…

Can AI support clinicians in diagnosing dementia? Aniekvangils (Amsterdam UMC) evaluates cNeuro in memory clinics as part of the @ihieurope funded IHI Prominent project. #BrainAwarenessWeek 🔗 ihi-prominent.eu/spotlight-on-e…

How can neuroimaging support early Alzheimer’s detection? Oriol Grau (Barcelonaβeta Brain Research Center) speaks about research in the @ihieurope funded IHI Prominent project. #BrainAwarenessWeek 🔗 ihi-prominent.eu/research-behin…

Multimodal prediction models for Alzheimer's disease could help patients better understand their future disease progression. Xin Xia Center for Alzheimer Research at KI is aiming to improve them in the public-private Innovative Health Initiative IHI Prominent project. ihi-prominent.eu/spotlight-on-e…

Public Involvement plays a key role in making digital health solutions patient-centered. Lena Sannemann explains how working with people with lived experience improves research in Innovative Health Initiative IHI Prominent project. #BrainAwarenessWeek 🔗 ihi-prominent.eu/spotlight-on-e…

Join us on 25-26 June 2025, at Schloss Birlinghoven, Fraunhofer SCAI IZB Campus, Sankt Augustin for the final JPND Research funded ADIS Symposium dedicated Towards Earlier Diagnosis of Alzheimer’s Disease⤵️ adis-project.eu/final-symposiu…

Registrations are open for the final symposium of the ADIS project, 25–26 June at Schloss Birlinghoven, Germany. Hear from leading EU projects PREDICTOM - IHI project,AD-RIDDLE & IHI Prominent and learn about the future of neurodegeneration research alzheimer-europe.org/news/registrat…

🚨 EMA issued a negative opinion on donanemab. PROMINENT responds with AI-driven tools to identify risks, collect real-world data & support equitable access. Thanks to Hanneke Rhodius-Meester (AmsterdamUMC & Oslo Univ. Hospital) for sharing her thoughts! ihi-prominent.eu/responding-to-…

Earlier today, Eisai and Biogen announced that the European Commission has decided to refer the marketing authorisation approval decision of #lecanemab in the EU to the Appeal Committee. alzheimer-europe.org/news/european-…

Meet Prof Dr Linus Jönsson, Health Economist at Karolinska Institutet. He will present @IHI_Prominent, developing a digital platform for precision medicine to support clinicians in diagnosing & managing neurodegenerative diseases. Register: adis-project.eu/final-symposiu…

Have a read of the latest Alzheimer Europe newsletter featuring an article on clinicians' perspectives on clinical decision support systems for Alzheimer’s disease, research conducted as part of the IHI Prominent project ⤵️

With #lecanemabauthorised in the EU, the @IHIeurope IHI Prominent project s helping address challenges in diagnosis, eligibility & clinical pathways for early #Alzheimer’s disease alzheimer-europe.org/news/prominent…

Makrina Daniilidou presented findings at #ADPD2025, explaining how comorbidities affect the reliability of blood-based biomarkers for Alzheimer’s diagnosis. We spoke with her about the implications for clinical use. Read the interview: ihi-prominent.eu/enhancing-diag…

Our second speaker at this European Parliament Lunch Debate is Linus Jönsson from Karolinska Institutet. He is discussing "Preparing for a new era of precision medicine in Europe – the contribution of the IHI Prominent project" #AELunchDebate

A huge thank you to our hosts, speakers and guests at today's #AELunchDebate in Brussels. Great presentations and discussions around the topic of "Preparing for new Alzheimer's treatments in Europe"! A big thank you, also, to all sponsors who made this event possible.

📢IHI-PROMINENT is at the #EuropeanParliament ! 🇪🇺 At the AE lunch debate on “Preparing for new Alzheimer’s treatments in Europe”, Linus Jönsson, co-lead of PROMINENT, talks about precision medicine in neurodegenerative disorders. 🧠#Alzheimers #dementia #digitalhealth

Our European Parliament lunch debate today focused on preparing for new Alzheimer’s treatments in Europe. Thank you to co-hosts Sirpa Pietikäinen🇫🇮🇪🇺 Romana Jerković Kraljić MEP & Hilde Vautmans and to speakers Sebastiaan Engelborghs @Linus Jönsson and Miia Kivipelto #AELunchDebate alzheimer-europe.org/news/alzheimer…

The @ihieurope funded @ihi_PROMINENT Newsletter #4 is out now. Highlights 🌟EU authorises lecanemab for early Alzheimer’s, clinician survey on decision support, latest biomarker research & Alzheimer Europe European Parliament debate. Read & subscribe: mailchi.mp/266ae009900a/p…